Security key
126650100
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,272,949,774
- Total 13F shares
- 850,535,070
- Share change
- +3,384,140
- Total reported value
- $54,718,204,845
- Put/Call ratio
- 89%
- Price per share
- $64.35
- Number of holders
- 1,560
- Value change
- +$271,208,332
- Number of buys
- 764
- Number of sells
- 730
Report period
Q2 2018
Institutions
1,560
Top holders
10
CVS full security history
Newer quarter: Q3 2018
Previous quarter: Q1 2018
CVS HEALTH Corp SEC filings
CVS HEALTH Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 126650100
Recent filing periods:
Top shareholders of CVS - CVS HEALTH Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
78,535,415
|
$4,885,688,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
70,013,482
|
$4,355,536,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
41,331,493
|
$2,571,231,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
2.6%
|
33,608,485
|
$2,090,784,000 | — | 31 Mar 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
20,683,900
|
$1,286,745,000 | — | 31 Mar 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
18,125,746
|
$1,127,602,000 | — | 31 Mar 2018 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
1.4%
|
18,102,755
|
$1,126,173,000 | — | 31 Mar 2018 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
1.3%
|
16,308,629
|
$1,014,560,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
15,471,670
|
$962,491,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
14,731,508
|
$916,447,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
14,656,287
|
$911,769,000 | — | 31 Mar 2018 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
1.1%
|
14,416,941
|
$896,878,000 | — | 31 Mar 2018 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.95%
|
12,149,443
|
$755,818,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
11,449,000
|
$710,606,000 | — | 31 Mar 2018 | |
| HARRIS ASSOCIATES L P |
13F
|
Company |
0.9%
|
11,429,785
|
$711,047,000 | — | 31 Mar 2018 | |
| Veritas Asset Management LLP |
13F
|
Company |
0.89%
|
11,381,924
|
$708,069,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.85%
|
10,844,055
|
$674,608,000 | — | 31 Mar 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.85%
|
10,775,834
|
$670,365,000 | — | 31 Mar 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.83%
|
10,514,440
|
$654,105,000 | — | 31 Mar 2018 | |
| NORGES BANK |
13F
|
Company |
0.79%
|
10,003,686
|
$622,329,000 | — | 31 Mar 2018 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.78%
|
9,897,439
|
$615,720,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.73%
|
9,346,551
|
$581,448,000 | — | 31 Mar 2018 | |
| Vulcan Value Partners, LLC |
13F
|
Company |
0.73%
|
9,305,338
|
$578,885,000 | — | 31 Mar 2018 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
7,794,388
|
$484,889,000 | — | 31 Mar 2018 | |
| Capital World Investors |
13F
|
Company |
0.58%
|
7,350,004
|
$457,244,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
7,066,306
|
$439,594,000 | — | 31 Mar 2018 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.55%
|
7,041,006
|
$438,021,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.55%
|
7,031,778
|
$437,447,000 | — | 31 Mar 2018 | |
| Boston Partners |
13F
|
Company |
0.55%
|
6,984,013
|
$434,475,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.51%
|
6,509,585
|
$404,963,000 | — | 31 Mar 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.5%
|
6,369,954
|
$396,236,000 | — | 31 Mar 2018 | |
| APG Asset Management N.V. |
13F
|
Company |
0.49%
|
6,195,127
|
$313,371,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.48%
|
6,111,111
|
$380,162,000 | — | 31 Mar 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.46%
|
5,880,181
|
$365,806,000 | — | 31 Mar 2018 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.45%
|
5,721,611
|
$355,941,000 | — | 31 Mar 2018 | |
| Legal & General Group Plc |
13F
|
Company |
0.44%
|
5,602,997
|
$348,552,000 | — | 31 Mar 2018 | |
| Capital Research Global Investors |
13F
|
Company |
0.36%
|
4,523,598
|
$281,413,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.35%
|
4,512,903
|
$280,747,000 | — | 31 Mar 2018 | |
| Sentry Investments Corp. |
13F
|
Company |
0.35%
|
4,450,500
|
$276,866,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.31%
|
3,958,795
|
$246,277,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.31%
|
3,928,349
|
$244,383,000 | — | 31 Mar 2018 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
3,903,132
|
$242,813,843 | — | 31 Mar 2018 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.29%
|
3,727,747
|
$231,903,000 | — | 31 Mar 2018 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.28%
|
3,615,881
|
$224,944,000 | — | 31 Mar 2018 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.27%
|
3,400,101
|
$211,520,000 | — | 31 Mar 2018 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.27%
|
3,377,691
|
$210,126,000 | — | 31 Mar 2018 | |
| Swiss National Bank |
13F
|
Company |
0.26%
|
3,299,510
|
$205,263,000 | — | 31 Mar 2018 | |
| Kiltearn Partners LLP |
13F
|
Company |
0.26%
|
3,272,295
|
$205,206,000 | — | 31 Mar 2018 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.25%
|
3,135,295
|
$195,047,000 | — | 31 Mar 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
3,054,397
|
$190,014,000 | — | 31 Mar 2018 |
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q2 2018
As of 30 Jun 2018,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,560 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
850,535,070 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BARROW HANLEY MEWHINNEY & STRAUSS LLC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, PARNASSUS INVESTMENTS /CA, and NORTHERN TRUST CORP.
This page lists
1,561
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
1,540
Q2 2018 holders
1,560
Holder diff
20
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.